Medicinal Cannabis Matters: Friday Roundup - 3 April 2026

Epilepsy, Access and the Ongoing Fight for Awareness

A recent report from the Mirror highlights the experience of families navigating access to medicinal cannabis for severe epilepsy. The article focuses on the life-changing impact medicinal cannabis can have in reducing seizure frequency, particularly in cases where conventional medications have not been effective.

At the same time, it emphasises the ongoing challenges some families face in accessing treatment. These stories continue to play an important role in raising awareness, helping to ensure that patients with complex conditions are not overlooked and that access remains part of the national conversation.

UK and Germany Markets See Significant Growth

A new report highlighted by Business of Cannabis reveals that both the UK and Germany’s medical cannabis markets doubled in size during 2025. This level of growth reflects increasing demand, wider awareness and continued expansion of prescribing frameworks.

For patients, market growth often translates into improved availability and broader product choice. As leading European markets continue to expand, the overall community supporting medicinal cannabis becomes stronger and more resilient.

Five Key Global Takeaways for Medicinal Cannabis in 2026

A global review from Prohibition Partners provides further insight into where the medicinal cannabis sector is heading. Among the key takeaways are continued international expansion, increased investment in research and a stronger focus on regulation and patient access.

The report also highlights the importance of education, both for clinicians and patients, as the sector continues to evolve. As understanding improves, so does the ability to deliver safe, effective and evidence-based care.

While healthcare systems vary, global trends often shape local progress, contributing to a more informed and connected approach to medicinal cannabis worldwide.

This week’s stories show how the medicinal cannabis industry is continuing to move forward with purpose. From patient advocacy in epilepsy care to strong market growth and global collaboration, we’re seeing greater awareness and more consistent access to treatment.

For patients, this means more confidence in exploring medicinal cannabis as part of a wider treatment plan, supported by specialist clinicians. If you are considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in under two minutes. The process is confidential and provides a clear starting point before speaking with a clinician.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.